Amgen vs ANI Pharmaceuticals

Amgen vs ANI Pharmaceuticals, compared side by side on 21 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Amgen is on 34/100 and ANI Pharmaceuticals on 49/100.

Amgen logo
AmgenA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
Try Amgen
ANI Pharmaceuticals logo
ANI PharmaceuticalsDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
Try ANI Pharmaceuticals

Where each one leads

Amgen

  • agent readiness: 41/100 against 31/100
  • domain rating: 80/100 against 56/100
  • headcount: 39,919 against 707
  • LinkedIn following: 1,697,311 against 31,660

ANI Pharmaceuticals

  • our overall score: 49/100 against 34/100
  • funding raised: $671M against $40.0M

At a glance

MeasureAmgenANI Pharmaceuticals
What it isA global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.Diversified biopharmaceutical company focused on rare diseases, generics, and established brands.
CategoryBiotech, MedTech, HealthTech, GenomicsBiotech, Pharmaceuticals, Rare Disease, Generics
Sells toBusiness modelB2BB2B
OfferingPlatformSoftware | hardware | services | marketplace | platform
Founded19801996
HeadquartersThousand Oaks, United StatesBaudette, United States
StatusActiveActive

Size, funding and growth

MeasureAmgenANI Pharmaceuticals
Employees39,919707
Headcount growthLast 12 monthsNot published+95.8%
Total funding$40.0M$671M
Latest roundIPOAcquisition
LinkedIn followers1,697,31131,660

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureAmgenANI Pharmaceuticals
StartupHub scoreOur 0-100 rating34/10049/100
Traction58/10060/100
Team70/10010/100
Community8/100Not published
Search visibility68/10023/100
Quality15/10058/100
Agent readinessHow well an AI agent can read and act on the siteD (41/100)F (31/100)
Domain ratingLink authority, 0-10080/10056/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureAmgenANI Pharmaceuticals
HostingAWSSelf Managed
CDNCloudFrontNot detected
FrameworksBootstrapJquery, Bootstrap
AnalyticsGoogle Tag ManagerGoogle Analytics 4

Amgen vs ANI Pharmaceuticals: common questions

Which is better, Amgen or ANI Pharmaceuticals?

On our 0-100 score ANI Pharmaceuticals rates higher (49/100 against 34/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 21 data points above: read the rows that match what you are buying for.

How do Amgen and ANI Pharmaceuticals compare on the numbers?

Amgen leads on agent readiness (41/100 against 31/100), domain rating (80/100 against 56/100), headcount (39,919 against 707), LinkedIn following (1,697,311 against 31,660). ANI Pharmaceuticals leads on our overall score (49/100 against 34/100), funding raised ($671M against $40.0M).

Read the full Amgen review and pricing or the ANI Pharmaceuticals review and pricing. You can also browse other Amgen alternatives we track.